NCT00593190CompletedNot Applicable
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
HaEmek Medical Center, Israel1 site in 1 country8 target enrollmentStarted: January 2008Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Hydrops resulotion
Study Overview
Brief Summary
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Age < 18 years old
Arms & Interventions
1
Experimental
Intervention: Gas SF6 (Sulfur Hexafluoride) (Drug)
Outcomes
Primary Outcomes
Hydrops resulotion
Time Frame: weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 2
Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon GasesSubretinal Hemorrhage and Exudative MaculopathyNCT00161525Weill Medical College of Cornell University25
Withdrawn
Not Applicable
Intravitreal Gas for Vitreomacular AdhesionVitreomacular AdhesionNCT02001701Northern California Retina Vitreous Associates
Not yet recruiting
Unknown
A clinical study to determine the safety and performance of Everads Injector for Injection of triamcinolone acetonide in suprachoroidal space of eye.CTRI/2024/01/061410Everads Therapy Ltd.
Terminated
Phase 1
Treatment of Macular Edema After Cataract Surgery with Subconjunctival AfliberceptIrvine-Gass SyndromeNCT03396861Tufts Medical Center1
Completed
Phase 1
Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus PatientsCorneal EctasiaKeratoconusNCT05241145iVeena Delivery Systems, Inc.38